9866:HKEXNIO Inc. Class A Analysis
Data as of 2026-06-18 - not real-time
HK$41.76
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
NIO (9866.HK) is trading at HK$41.76, well below its 20‑day SMA of HK$43.17, 50‑day SMA of HK$47.00 and 200‑day SMA of HK$45.97, indicating a short‑term bearish bias. The RSI of 44.2 sits in neutral territory while the MACD remains bearish (line below signal), and volume is on a decreasing trend, suggesting limited upward momentum. Despite these technical headwinds, the company posted a 112% YoY revenue growth and a 62% YoY jump in vehicle deliveries in May 2026, underscoring strong top‑line momentum. However, profitability is still negative (operating margin –1.2%, profit margin –9.1%) and cash flow is flat, while the balance sheet shows a high debt‑to‑equity ratio of 183% against modest cash reserves, raising solvency concerns. The forward PE of 18.1 and a consensus target median price of HK$55.0 imply upside potential of roughly 30%, yet the stock trades at a lofty price‑to‑book of 20.6 and a high volatility of 58% (30‑day).
Regulatory risk has risen after the U.S. Department of Defense placed NIO on its “Chinese military companies” list, which could constrain access to certain markets and financing. Coupled with a low beta of 0.24 (limited market sensitivity) but high sector exposure to consumer cyclical trends, the overall risk profile is moderate‑to‑high. Investors should weigh the strong delivery growth and forward earnings against the weak margins, elevated debt, and heightened regulatory scrutiny when forming a view on the stock.
Regulatory risk has risen after the U.S. Department of Defense placed NIO on its “Chinese military companies” list, which could constrain access to certain markets and financing. Coupled with a low beta of 0.24 (limited market sensitivity) but high sector exposure to consumer cyclical trends, the overall risk profile is moderate‑to‑high. Investors should weigh the strong delivery growth and forward earnings against the weak margins, elevated debt, and heightened regulatory scrutiny when forming a view on the stock.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Price below short‑term moving averages
- Bearish MACD and decreasing volume
- Support level at HK$39.36 providing limited downside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Robust YoY delivery growth and revenue expansion
- Forward PE of 18 suggesting reasonable valuation relative to earnings outlook
- Target median price indicating ~30% upside
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term EV market tailwinds in China and Europe
- Continued innovation in battery‑swap and charging services
- Potential resolution of regulatory issues and improvement in profitability
Key Metrics & Analysis
Financial Health
Revenue Growth112.20%
Profit Margin-9.09%
P/E Ratio18.1
ROE-83.96%
ROA-4.42%
Debt/Equity183.30
P/B Ratio20.6
Technical Analysis
TrendNeutral
RSI44.2
SupportHK$39.36
ResistanceHK$49.38
MA 20HK$43.17
MA 50HK$47.00
MA 200HK$45.97
MACDBearish
VolumeDecreasing
Fear & Greed Index88.5
Valuation
Target PriceHK$56.15
Upside/Downside34.47%
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.24
Volatility58.12%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.